A pilot study evaluating sofosbuvir-based anti-viral regimen for the treatment of chronic hepatitis C virus (HCV) infection in kidney transplant recipients

Trial Profile

A pilot study evaluating sofosbuvir-based anti-viral regimen for the treatment of chronic hepatitis C virus (HCV) infection in kidney transplant recipients

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Nov 2015

At a glance

  • Drugs Sofosbuvir (Primary) ; Daclatasvir; Ledipasvir/sofosbuvir; Peginterferon alfa-2a; Ribavirin; Simeprevir
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Nov 2015 New trial record
    • 20 Nov 2015 Results published in the American Journal of Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top